Trade and other payables

12 Months Ended

Jun. 30, 2026

7. Trade and other payables


(US$’000)	June 30, 2026		June 30, 2025
Trade payable	$	913	$	201
Accrued consultant fees		95		36
Accrued professional fees		16		62
Accrued clinical development project costs		2,420		656
Third-party procured supplies and materials		738		—
Other payables		113		67
Total	$	4,295	$	1,022

During the year ended June 30, 2025, the Company agreed to resolve disputed trade payables and accrued clinical development project costs of $1.2 million with a vendor for $0.5 million. This settlement resulted in a gain of $0.8 million recorded in the consolidated statement of operations and other comprehensive loss under other income (expense) for the period. No comparable settlements occurred during the year ended June 30, 2026.